The RAI-6 questionnaire: a new screening questionnaire to monitor complications of radioiodine treatment

Objective: The aim of this study is to develop a simple and efficient screening questionnaire to be able to routinely monitor potential radioiodine therapy-induced complications. Materials and Methods: A new radioiodine 6 (RAI-6) questionnaire containing six questions adressing salivary, ocular, and...

Full description

Bibliographic Details
Main Authors: Buchholzer, Samanta, Thakachy, Subha Sethu, Tchérémissinoff, Livia, Boselie, Franciscus, Triponez, Frédéric, Faure, Frédéric, Lopez, Jean Michel, Borner, Urs, Kleinjung, Tobias, Seebach, Jörg D., Dulguerov, Pavel, Marchal, Francis
Format: Article
Language:English
Published: Frontiers Research Foundation 2021
Online Access:http://psasir.upm.edu.my/id/eprint/95573/
http://psasir.upm.edu.my/id/eprint/95573/1/The%20RAI-6%20questionnaire%3B%20a%20new%20screening%20questionnaire%20to%20monitor%20complications%20of%20radioiodine%20treatment.pdf
_version_ 1848862193083219968
author Buchholzer, Samanta
Thakachy, Subha Sethu
Tchérémissinoff, Livia
Boselie, Franciscus
Triponez, Frédéric
Faure, Frédéric
Lopez, Jean Michel
Borner, Urs
Kleinjung, Tobias
Seebach, Jörg D.
Dulguerov, Pavel
Marchal, Francis
author_facet Buchholzer, Samanta
Thakachy, Subha Sethu
Tchérémissinoff, Livia
Boselie, Franciscus
Triponez, Frédéric
Faure, Frédéric
Lopez, Jean Michel
Borner, Urs
Kleinjung, Tobias
Seebach, Jörg D.
Dulguerov, Pavel
Marchal, Francis
author_sort Buchholzer, Samanta
building UPM Institutional Repository
collection Online Access
description Objective: The aim of this study is to develop a simple and efficient screening questionnaire to be able to routinely monitor potential radioiodine therapy-induced complications. Materials and Methods: A new radioiodine 6 (RAI-6) questionnaire containing six questions adressing salivary, ocular, and nasal symptoms as well as quality of life was developed. Validation of the RAI-6 questionnaire was assessed with a group of fifty-four patients diagnosed with differentiated thyroid carcinoma treated post-operatively with radioiodine therapy, and in a group of fifty healthy volunteers. The patient’s group was subdivided into subgroups according to the radioiodine dose received: 23 patients received less or 30 mCi, 28 patients received 100 mCi, and three patients received between 200 and 300 mCi. We asked the patients to complete the RAI-6 questionnaire in a retrospective manner, regarding their situation before radioiodine therapy and regarding their actual symptoms after radioiodine therapy. The time needed to complete the RAI-6 was also assessed both in patients and in healthy volunteers. Results: The mean post radioiodine treatment RAI-6 score were significantly higher than the mean pre radioiodine RAI-6 scores (p < 0.001) and the scores of healthy participants (p < 0.001). The mean total RAI-6 scores increased significantly with increasing radioiodine dose. A total mean RAI-6 score of each question was also analysed and revealed that ocular and nasal discomfort as well as quality of life were the items which affected the patients most after radioiodine treatment. The mean time to fill the RAI-6 questionnaire was 2 min for patients and 49 s for healthy volunteers. Conclusion: The RAI-6 represents a new questionnaire which is easy and quick to complete. This simple screening tool can be recommended for general clinical practise and further epidemiological research.
first_indexed 2025-11-15T13:13:08Z
format Article
id upm-95573
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T13:13:08Z
publishDate 2021
publisher Frontiers Research Foundation
recordtype eprints
repository_type Digital Repository
spelling upm-955732022-08-22T01:56:34Z http://psasir.upm.edu.my/id/eprint/95573/ The RAI-6 questionnaire: a new screening questionnaire to monitor complications of radioiodine treatment Buchholzer, Samanta Thakachy, Subha Sethu Tchérémissinoff, Livia Boselie, Franciscus Triponez, Frédéric Faure, Frédéric Lopez, Jean Michel Borner, Urs Kleinjung, Tobias Seebach, Jörg D. Dulguerov, Pavel Marchal, Francis Objective: The aim of this study is to develop a simple and efficient screening questionnaire to be able to routinely monitor potential radioiodine therapy-induced complications. Materials and Methods: A new radioiodine 6 (RAI-6) questionnaire containing six questions adressing salivary, ocular, and nasal symptoms as well as quality of life was developed. Validation of the RAI-6 questionnaire was assessed with a group of fifty-four patients diagnosed with differentiated thyroid carcinoma treated post-operatively with radioiodine therapy, and in a group of fifty healthy volunteers. The patient’s group was subdivided into subgroups according to the radioiodine dose received: 23 patients received less or 30 mCi, 28 patients received 100 mCi, and three patients received between 200 and 300 mCi. We asked the patients to complete the RAI-6 questionnaire in a retrospective manner, regarding their situation before radioiodine therapy and regarding their actual symptoms after radioiodine therapy. The time needed to complete the RAI-6 was also assessed both in patients and in healthy volunteers. Results: The mean post radioiodine treatment RAI-6 score were significantly higher than the mean pre radioiodine RAI-6 scores (p < 0.001) and the scores of healthy participants (p < 0.001). The mean total RAI-6 scores increased significantly with increasing radioiodine dose. A total mean RAI-6 score of each question was also analysed and revealed that ocular and nasal discomfort as well as quality of life were the items which affected the patients most after radioiodine treatment. The mean time to fill the RAI-6 questionnaire was 2 min for patients and 49 s for healthy volunteers. Conclusion: The RAI-6 represents a new questionnaire which is easy and quick to complete. This simple screening tool can be recommended for general clinical practise and further epidemiological research. Frontiers Research Foundation 2021-09 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/95573/1/The%20RAI-6%20questionnaire%3B%20a%20new%20screening%20questionnaire%20to%20monitor%20complications%20of%20radioiodine%20treatment.pdf Buchholzer, Samanta and Thakachy, Subha Sethu and Tchérémissinoff, Livia and Boselie, Franciscus and Triponez, Frédéric and Faure, Frédéric and Lopez, Jean Michel and Borner, Urs and Kleinjung, Tobias and Seebach, Jörg D. and Dulguerov, Pavel and Marchal, Francis (2021) The RAI-6 questionnaire: a new screening questionnaire to monitor complications of radioiodine treatment. Frontiers in Surgery, 8. art. no. 641945. pp. 1-6. ISSN 2296-875X https://www.frontiersin.org/articles/10.3389/fsurg.2021.641945/full 10.3389/fsurg.2021.641945
spellingShingle Buchholzer, Samanta
Thakachy, Subha Sethu
Tchérémissinoff, Livia
Boselie, Franciscus
Triponez, Frédéric
Faure, Frédéric
Lopez, Jean Michel
Borner, Urs
Kleinjung, Tobias
Seebach, Jörg D.
Dulguerov, Pavel
Marchal, Francis
The RAI-6 questionnaire: a new screening questionnaire to monitor complications of radioiodine treatment
title The RAI-6 questionnaire: a new screening questionnaire to monitor complications of radioiodine treatment
title_full The RAI-6 questionnaire: a new screening questionnaire to monitor complications of radioiodine treatment
title_fullStr The RAI-6 questionnaire: a new screening questionnaire to monitor complications of radioiodine treatment
title_full_unstemmed The RAI-6 questionnaire: a new screening questionnaire to monitor complications of radioiodine treatment
title_short The RAI-6 questionnaire: a new screening questionnaire to monitor complications of radioiodine treatment
title_sort rai-6 questionnaire: a new screening questionnaire to monitor complications of radioiodine treatment
url http://psasir.upm.edu.my/id/eprint/95573/
http://psasir.upm.edu.my/id/eprint/95573/
http://psasir.upm.edu.my/id/eprint/95573/
http://psasir.upm.edu.my/id/eprint/95573/1/The%20RAI-6%20questionnaire%3B%20a%20new%20screening%20questionnaire%20to%20monitor%20complications%20of%20radioiodine%20treatment.pdf